Dr. Clair Cascella, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,949 | 245 | 98.1% |
| Education | $93.49 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,291 | 69 | $0 (2024) |
| Allergan, Inc. | $431.67 | 29 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $404.99 | 17 | $0 (2022) |
| Amgen Inc. | $300.92 | 5 | $0 (2024) |
| Lilly USA, LLC | $222.38 | 10 | $0 (2024) |
| Lundbeck LLC | $172.63 | 7 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $165.80 | 15 | $0 (2022) |
| Eisai Inc. | $163.43 | 6 | $0 (2024) |
| PFIZER INC. | $162.46 | 18 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $159.20 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,207 | 59 | ABBVIE INC. ($483.34) |
| 2023 | $766.71 | 36 | AbbVie Inc. ($379.77) |
| 2022 | $814.73 | 42 | Teva Pharmaceuticals USA, Inc. ($237.90) |
| 2021 | $813.45 | 40 | AbbVie Inc. ($313.26) |
| 2020 | $470.18 | 35 | Allergan, Inc. ($234.34) |
| 2019 | $209.62 | 6 | Amgen Inc. ($125.00) |
| 2018 | $175.04 | 4 | Amgen Inc. ($116.88) |
| 2017 | $585.78 | 24 | Medtronic Vascular, Inc. ($139.40) |
All Payment Transactions
246 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.00 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 11/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.00 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: PAIN | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Immunology | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: PAIN | ||||||
| 11/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $33.81 | General |
| Category: Neurology | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.48 | General |
| Category: PAIN | ||||||
| 10/25/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.00 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: PAIN | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: PAIN | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $33.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $31.86 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 10/08/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $31.86 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 09/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.00 | General |
| Category: NEUROLOGY | ||||||
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: PAIN | ||||||
| 08/20/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $47.91 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 08/19/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,057 | 1,540 | $413,137 | $206,335 |
| 2022 | 16 | 742 | 1,061 | $360,592 | $148,058 |
| 2021 | 21 | 655 | 899 | $187,347 | $118,797 |
| 2020 | 13 | 438 | 784 | $110,213 | $80,046 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 190 | 530 | $90,632 | $47,682 | 52.6% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 143 | 173 | $74,233 | $39,010 | 52.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 193 | $42,654 | $21,837 | 51.2% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 54 | 55 | $27,335 | $14,413 | 52.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 39 | 39 | $26,676 | $14,283 | 53.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 51 | 58 | $21,228 | $10,946 | 51.6% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 54 | 54 | $26,136 | $10,874 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $17,691 | $9,174 | 51.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 51 | 51 | $28,621 | $9,011 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 86 | $13,503 | $6,771 | 50.1% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2023 | 50 | 51 | $11,628 | $5,877 | 50.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 35 | 36 | $10,944 | $5,829 | 53.3% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 50 | 51 | $10,190 | $4,819 | 47.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $6,304 | $3,253 | 51.6% |
| 92537 | Test to assess balance during warm and cool irrigation in both ears | Office | 2023 | 50 | 51 | $3,519 | $1,823 | 51.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 13 | 19 | $1,843 | $733.20 | 39.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 132 | 356 | $83,718 | $34,295 | 41.0% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 85 | 99 | $60,884 | $23,633 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 171 | $39,117 | $19,561 | 50.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 48 | 54 | $27,600 | $11,016 | 39.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 29 | 29 | $23,334 | $10,611 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $21,922 | $9,200 | 42.0% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2022 | 32 | 32 | $21,622 | $8,503 | 39.3% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 32 | 32 | $21,361 | $6,583 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 69 | $12,035 | $5,775 | 48.0% |
About Dr. Clair Cascella, M.D
Dr. Clair Cascella, M.D is a Neuromusculoskeletal Medicine & OMM healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2012. The National Provider Identifier (NPI) number assigned to this provider is 1962777169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clair Cascella, M.D has received a total of $5,042 in payments from pharmaceutical and medical device companies, with $1,207 received in 2024. These payments were reported across 246 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,949).
As a Medicare-enrolled provider, Cascella has provided services to 2,892 Medicare beneficiaries, totaling 4,284 services with total Medicare billing of $553,237. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Neuromusculoskeletal Medicine & OMM
- Location New Hyde Park, NY
- Active Since 03/20/2012
- Last Updated 03/20/2014
- Taxonomy Code 204D00000X
- Entity Type Individual
- NPI Number 1962777169
Products in Payments
- UBRELVY (Drug) $706.09
- QULIPTA (Drug) $654.63
- BOTOX (Biological) $324.12
- NURTEC ODT (Drug) $317.93
- Aimovig (Biological) $286.46
- AJOVY (Biological) $172.09
- RYTARY (Drug) $159.20
- VYEPTI (Biological) $153.47
- CardioInsight (Device) $139.40
- XCOPRI (Drug) $125.00
- Xtampza ER (Drug) $125.00
- PERCEPT PC BRAINSENSE (Device) $123.36
- Leqembi (Drug) $116.51
- GILENYA (Drug) $104.85
- EMGALITY (Drug) $102.85
- AMYVID (Drug) $102.30
- AUSTEDO (Drug) $94.12
- VALTOCO (Drug) $92.21
- Briviact (Drug) $66.73
- NEUROSTAR TMS THERAPY SYSTEM (Device) $63.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.